1. Home
  2. GDL vs CSBR Comparison

GDL vs CSBR Comparison

Compare GDL & CSBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDL
  • CSBR
  • Stock Information
  • Founded
  • GDL 2006
  • CSBR 1985
  • Country
  • GDL United States
  • CSBR United States
  • Employees
  • GDL N/A
  • CSBR N/A
  • Industry
  • GDL Investment Managers
  • CSBR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • GDL Finance
  • CSBR Health Care
  • Exchange
  • GDL Nasdaq
  • CSBR Nasdaq
  • Market Cap
  • GDL 93.8M
  • CSBR 111.4M
  • IPO Year
  • GDL N/A
  • CSBR 1986
  • Fundamental
  • Price
  • GDL $8.30
  • CSBR $8.33
  • Analyst Decision
  • GDL
  • CSBR Strong Buy
  • Analyst Count
  • GDL 0
  • CSBR 1
  • Target Price
  • GDL N/A
  • CSBR $12.00
  • AVG Volume (30 Days)
  • GDL 11.2K
  • CSBR 39.6K
  • Earning Date
  • GDL 01-01-0001
  • CSBR 09-10-2025
  • Dividend Yield
  • GDL 6.02%
  • CSBR N/A
  • EPS Growth
  • GDL N/A
  • CSBR N/A
  • EPS
  • GDL N/A
  • CSBR 0.46
  • Revenue
  • GDL N/A
  • CSBR $58,591,000.00
  • Revenue This Year
  • GDL N/A
  • CSBR $15.11
  • Revenue Next Year
  • GDL N/A
  • CSBR $7.80
  • P/E Ratio
  • GDL N/A
  • CSBR $17.71
  • Revenue Growth
  • GDL N/A
  • CSBR 19.03
  • 52 Week Low
  • GDL $7.65
  • CSBR $3.60
  • 52 Week High
  • GDL $8.13
  • CSBR $11.99
  • Technical
  • Relative Strength Index (RSI)
  • GDL 49.06
  • CSBR 64.00
  • Support Level
  • GDL $8.25
  • CSBR $7.16
  • Resistance Level
  • GDL $8.37
  • CSBR $9.63
  • Average True Range (ATR)
  • GDL 0.07
  • CSBR 0.64
  • MACD
  • GDL -0.01
  • CSBR 0.11
  • Stochastic Oscillator
  • GDL 36.69
  • CSBR 69.06

About GDL GDL Fund The of Beneficial Interest

GDL Fund is a diversified closed-end management investment company. Its primary investment objective is to achieve absolute returns in various market conditions without excessive risk of capital. The fund seeks to achieve its objective by investing in merger arbitrage transactions and, to a lesser extent, in corporate reorganizations involving stubs, spin-offs, and liquidations.

About CSBR Champions Oncology Inc.

Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.

Share on Social Networks: